Exchange: NASDAQ·Updated 03:33 PM EST

GCTK News

News
all
press releases
Glucotrack, Inc. Announces Reverse Stock Split
Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a healthcare technology and biopharmaceutical company operating Lkahi Therapeutics, today announced that it will effect a 1-for-2 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock, par value $0.001...
Business Wire
Glucotrack, Inc. Announces Reverse Stock Split
Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a healthcare technology and biopharmaceutical company operating Lkahi Therapeutics, today announced that it will effect a 1-for-2 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock, par value $0.001...
Business Wire
More News
Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced the public launch of Qare, a comparative health platform designed to help users compare self-reported treatment experiences across medications within the same therapeutic class. Launching initially in the GLP-1...
Business Wire
Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced a new international project with the University of Georgia's Student Industry Fellows Program and Universitt Paderborn's garage33 entrepreneurship and innovation center. The Fall 2026 initiative represents the...
Business Wire
Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced Qare, a comparative health platform designed to evaluate treatment outcomes by comparing experiences across patients using different medications within the same therapeutic class. Introduced on National GLP-1 Day...
Business Wire
Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced that it will partner with Pepperdine E2B (Education to Business) to engage students in its ai2 Pipeline initiative during the upcoming academic year. The collaboration is intended to provide students with hands-on...
Business Wire
The market is watching a diverse group of companies as catalysts converge. NeOnc Technologies Holdings (NASDAQ:NTHI) attracted fresh Wall Street coverage around its brain-cancer pipeline; Profusa (NASDAQ:PFSA) is moving closer to a potential European regulatory milestone; Sky Quarry (NASDAQ:SKYQ) restarted Nevada's Eagle Springs Refinery; Glucotrack (NASDAQ:GCTK) is turning its Lōkahi asset-discovery platform toward external revenue; while Greenland Mines Ltd. (NASDAQ:GRML) and Greenland Energy Company (NASDAQ:GLND) are advancing separate projects in Greenland.
24-7 Market News
GlucoTrack subsidiary Lokahi Therapeutics secured its first external fee-for-service partnership with nonprofit Innovate GBM for glioblastoma research.read more...
Benzinga
The markets are producing a striking mix of catalysts, with NeOnc (NASDAQ:NTHI), Kraig Biocraft Laboratories (OTCQB:KBLB), Profusa (NASDAQ:PFSA), Sky Quarry (NASDAQ: SKYQ), Glucotrack (NASDAQ:GCTK) and Greenland Mines (NASDAQ:GRML) all generating fresh developments.
24-7 Market News
Glucotrack, Inc. (NASDAQ: GCTK) (Glucotrack or the Company) today announced the pricing of a best efforts public offering of 169,388 shares of common stock at a price of $2.04 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase up to 1,350,220...
Business Wire
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. Theread more...
Benzinga

Advertisement|Remove ads.